World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
169
Citations
114114
World Ranking
908
National Ranking
536

Medicine

D-Index
169
Citations
115228
World Ranking
541
National Ranking
318

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

Herbert Y. Meltzer is affiliated with Northwestern University in the United States. The researcher's work primarily spans the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Neuroscience. Within these fields, Meltzer's subfields of study include Psychiatry and Mental Health, Molecular Biology, Cellular and Molecular Neuroscience, Genetics, and Clinical Psychology.

The main topics covered by Meltzer's research include Schizophrenia Research and Treatment, Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Bipolar Disorder and Treatment, Mental Health and Psychiatry, and Genetic Associations and Epidemiology.

Recent publications by Herbert Y. Meltzer demonstrate a focus on psychiatry and neuroscience with an emphasis on schizophrenia and psychopharmacology. Selected papers include:

  • Respiratory Microbial Co-infection With SARS-CoV-2, 2020, Frontiers in Microbiology
  • Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia, 2020, Journal of Clinical Psychopharmacology
  • Contrasting Typical and Atypical Antipsychotic Drugs, 2021, FOCUS The Journal of Lifelong Learning in Psychiatry
  • Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group, 2023, Schizophrenia Bulletin
  • Depolarizing GABA A current in the prefrontal cortex is linked with cognitive impairment in a mouse model relevant for schizophrenia, 2021, Science Advances

The frequent coauthors contributing to Meltzer's research output include:

  • Lakshmi Rajagopal
  • James L. Kennedy
  • Arun K. Tiwari
  • Jeffrey A. Lieberman
  • Mei Huang

Meltzer has published recurrently in several academic venues. Most notable publication venues include:

  • UNC Libraries
  • Behavioural Brain Research
  • SSRN Electronic Journal
  • Journal of Clinical Psychopharmacology
  • Schizophrenia Bulletin

Best Publications

  • Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

    John Kane;Gilbert Honigfeld;Jack Singer;Herbert Meltzer

  • Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

    Grazyna Rajkowska;José J Miguel-Hidalgo;Jinrong Wei;Ginny Dilley

  • Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

    H Y Meltzer;S Matsubara;J C Lee

  • Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

    Herbert Y. Meltzer;Larry Alphs;Alan I. Green;A. Carlo Altamura

  • Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

    Joseph Patrick McEvoy;Jonathan M. Meyer;Donald C. Goff;Henry A. Nasrallah

  • The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia

    Herbert Y. Meltzer;Susan R. McGurk

  • Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial

    Richard S.E. Keefe;Robert M. Bilder;Sonia M. Davis;Philip D. Harvey

  • Practice guideline for the treatment of patients with schizophrenia

    M. I. Herz;R. P. Liberman;T. H. McGlashan;J. A. Lieberman

  • The Dopamine Hypothesis of Schizophrenia: A Review*

    Herbert Y. Meltzer;Stephen M. Stahl

  • Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

    Joseph Patrick McEvoy;Jeffrey A. Lieberman;T. Scott Stroup;Sonia M. Davis

  • Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

    Oliver D. Howes;Rob McCutcheon;Ofer Agid;Andrea De Bartolomeis

  • H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

    Wesley Kars Kroeze;Sandra J. Hufeisen;Beth A. Popadak;Sean M. Renock

  • Serotonin receptors: their key role in drugs to treat schizophrenia.

    Herbert Y Meltzer;Zhu Li;Yasuhiro Kaneda;Junji Ichikawa

  • The role of serotonin in antipsychotic drug action

    Herbert Y Meltzer

  • Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

    B L Roth;S C Craigo;M S Choudhary;A Uluer

  • Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.

    Herbert Y. Meltzer

  • Cellular changes in the postmortem hippocampus in major depression.

    Craig A. Stockmeier;Craig A. Stockmeier;Gouri J. Mahajan;Lisa C. Konick;James C. Overholser

  • A novel augmentation strategy for treating resistant major depression.

    Richard C. Shelton;Gary D. Tollefson;Mauricio Tohen;Stephen Stahl

  • Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

    Michael Maes;Herbert Y. Meltzer;Eugène Bosmans;Raf Bergmans

  • A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia

    Neil D. Woodward;Scot E. Purdon;Herbert Y. Meltzer;David H. Zald

Frequent Co-Authors

James L. Kennedy
James L. Kennedy Centre for Addiction and Mental Health
Jeffrey A. Lieberman
Jeffrey A. Lieberman Columbia University
Michael Maes
Michael Maes University of Electronic Science and Technology of China
Craig A. Stockmeier
Craig A. Stockmeier University of Mississippi Medical Center
Gary Remington
Gary Remington Centre for Addiction and Mental Health
Steven G. Potkin
Steven G. Potkin University of California, Irvine
James C. Overholser
James C. Overholser Case Western Reserve University
Aristotle N. Voineskos
Aristotle N. Voineskos Centre for Addiction and Mental Health
Lee Friedman
Lee Friedman Texas State University
Joseph R. Calabrese
Joseph R. Calabrese Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA isn’t the only route to a rewarding healthcare career. Many students choose alternative and flexible education options that can be completed online. For instance, adn nursing programs offer a quicker path into registered nursing for those wanting hands-on patient care roles.

If you’re interested in the administrative side of healthcare, there are medical coding and billing classes online with financial aid, which help students enter this vital field without heavy upfront costs. Prospective nurses seeking efficient entry into the workforce can also explore an lpn program no entrance exam, making the admissions process less stressful and more accessible.

For those aiming for leadership roles, an accelerated healthcare administration degree allows you to quickly develop managerial skills needed in healthcare organizations. These alternative pathways make it easier than ever to start or advance your career in the health sector without the traditional barriers.

Best Scientists Citing Herbert Y. Meltzer

Trending Scientists

Recently Published Articles